F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
serum free fatty acids level |
fasting |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood free fatty acid amount |
male |
217 days
| 20 |
0.85 |
mmol/l |
0.05 |
0.23 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
66185 |
716 |
F344/NSlc |
serum free fatty acids level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood free fatty acid amount |
male |
218 days
| 7 |
0.67 |
mmol/l |
0.07 |
0.18 |
serum free fatty acid analysis |
|
0.0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
67495 |
311 |
PD/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
300 days
| 6 |
1.05 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70228 |
1318 |
SHR/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
98 days
| 10 |
0.02 |
mmol/l |
0.0 |
0.01 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67921 |
263 |
WKY/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
98 days
| 10 |
0.02 |
mmol/l |
0.0 |
0.0 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67923 |
263 |
F344.ZUC-Leprfa/Tj |
serum free fatty acids level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood free fatty acid amount |
male |
175 days
| 7 |
1.72 |
mmol/l |
0.37 |
0.98 |
serum free fatty acid analysis |
|
0.0 |
0 |
NEFA-C test kit (Wako Chem. LTD) |
|
98076 |
1978 |
SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91 days
| 7 |
30.61 |
mmol/l |
8.11 |
21.46 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
**suspected wrong units in paper(mg/dl) |
101855 |
2641 |
SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
male |
120 days-140 days |
24 |
180.0 |
mmol/l |
17.0 |
83.28 |
automated serum analysis |
|
0.0 |
0 |
|
|
107616 |
3093 |
BN/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
300 days
| 6 |
1.12 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70229 |
1318 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum free fatty acids level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood free fatty acid amount |
male |
218 days
| 7 |
0.75 |
mmol/l |
0.05 |
0.14 |
serum free fatty acid analysis |
|
0.0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
67496 |
311 |
WKY/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
female |
91 days
| 5 |
0.68 |
mmol/l |
0.12 |
0.27 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64867 |
115 |
SHRSP/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
female |
91 days
| 5 |
0.6 |
mmol/l |
0.05 |
0.11 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64865 |
115 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum free fatty acids level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood free fatty acid amount |
male |
218 days
| 11 |
0.66 |
mmol/l |
0.05 |
0.16 |
serum free fatty acid analysis |
|
0.0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
67497 |
311 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum free fatty acids level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood free fatty acid amount |
male |
218 days
| 11 |
0.68 |
mmol/l |
0.05 |
0.15 |
serum free fatty acid analysis |
|
0.0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
|
67498 |
311 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
307 days
| 6 |
1.56 |
mmol/l |
0.04 |
0.1 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70230 |
1318 |
BN/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
307 days
| 6 |
1.26 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70231 |
1318 |
SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood free fatty acid amount |
male |
91 days
| 6 |
1.42 |
mmol/l |
0.14 |
0.34 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
101953 |
2644 |
SHRSP/A3N |
serum free fatty acids level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
male |
120 days-140 days |
10 |
485.0 |
mmol/l |
42.0 |
132.82 |
automated serum analysis |
|
0.0 |
0 |
|
|
107617 |
3093 |
BN/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
310 days
| 6 |
1.4 |
mmol/l |
0.08 |
0.2 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70235 |
1318 |
SHRSP/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
male |
91 days
| 5 |
0.61 |
mmol/l |
0.08 |
0.18 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64862 |
115 |
WKY/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
male |
91 days
| 5 |
0.39 |
mmol/l |
0.02 |
0.04 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64864 |
115 |
SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91 days
| 12 |
19.47 |
mmol/l |
1.16 |
4.02 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
**suspected wrong units in paper(mg/dl) |
101856 |
2641 |
PD/Cub |
serum free fatty acids level |
controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) then fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
310 days
| 6 |
4.13 |
mmol/l |
0.12 |
0.3 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70234 |
1318 |
WKY/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
113 days
| 10 |
0.03 |
mmol/l |
0.0 |
0.01 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67924 |
263 |
SHRSP/A3N |
serum free fatty acids level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
female |
120 days-140 days |
15 |
796.0 |
mmol/l |
61.0 |
236.25 |
automated serum analysis |
|
0.0 |
0 |
|
|
107619 |
3093 |
SS.ZUC-Leprfa+/+/Slc |
serum free fatty acids level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91 days
| 10 |
15.09 |
mmol/l |
1.17 |
3.69 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
**suspected wrong units in paper(mg/dl) |
101854 |
2641 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
female |
91 days
| 5 |
0.77 |
mmol/l |
0.06 |
0.13 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64866 |
115 |
F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj |
serum free fatty acids level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood free fatty acid amount |
male |
175 days
| 5 |
1.06 |
mmol/l |
0.08 |
0.18 |
serum free fatty acid analysis |
|
0.0 |
0 |
NEFA-C test kit (Wako Chem. LTD) |
|
98077 |
1978 |
SS.ZUC-Leprfa+/+/Slc |
serum free fatty acids level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91 days
| 8 |
15.07 |
mmol/l |
0.66 |
1.86 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
**suspected wrong units in paper(mg/dl) |
101853 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood free fatty acid amount |
male |
91 days
| 7 |
0.59 |
mmol/l |
0.03 |
0.08 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
101955 |
2644 |
SHR/Izm |
serum free fatty acids level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood free fatty acid amount |
male |
113 days
| 10 |
0.02 |
mmol/l |
0.0 |
0.01 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
67922 |
263 |
SHR/OlaIpcv |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
0 days
| 6 |
1.28 |
mmol/l |
0.02 |
0.04 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70288 |
1318 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum free fatty acids level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood free fatty acid amount |
male |
91 days
| 5 |
0.43 |
mmol/l |
0.03 |
0.07 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
64863 |
115 |
SHR.PD-(D8Mgh9-D8Rat149)/Cub |
serum free fatty acids level |
fasting (for 16 hours) |
Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. |
blood free fatty acid amount |
male |
0 days
| 6 |
1.58 |
mmol/l |
0.04 |
0.09 |
liquid phase colorimetry |
retroorbital plexus |
0.0 |
0 |
|
|
70289 |
1318 |
SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood free fatty acid amount |
male |
91 days
| 7 |
0.61 |
mmol/l |
0.05 |
0.13 |
serum free fatty acid analysis |
|
0.0 |
0 |
|
|
101954 |
2644 |
F344/NSlc |
serum free fatty acids level |
fasting |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
blood free fatty acid amount |
male |
217 days
| 9 |
0.64 |
mmol/l |
0.06 |
0.17 |
serum free fatty acid analysis |
|
0 |
0 |
|
|
66184 |
716 |
SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
female |
120 days-140 days |
24 |
180.0 |
mmol/l |
16.0 |
78.38 |
automated serum analysis |
|
0.0 |
0 |
|
|
107618 |
3093 |